Cargando…

Drug–Drug Interactions of Cannabidiol with Standard-of-Care Chemotherapeutics

Cannabidiol (CBD) is an easily accessible and affordable Marijuana (Cannabis sativa L.) plant derivative with an extensive history of medical use spanning thousands of years. Interest in the therapeutic potential of CBD has increased in recent years, including its anti-tumour properties in various c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buchtova, Tereza, Lukac, David, Skrott, Zdenek, Chroma, Katarina, Bartek, Jiri, Mistrik, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917508/ https://www.ncbi.nlm.nih.gov/pubmed/36769206 http://dx.doi.org/10.3390/ijms24032885

Ejemplares similares

A drug repurposing strategy for overcoming human multiple myeloma resistance to standard-of-care treatment
por: Chroma, Katarina, et al.
Publicado: (2022)

Cannabidiol‐induced activation of the metallothionein pathway impedes anticancer effects of disulfiram and its metabolite CuET
por: Buchtova, Tereza, et al.
Publicado: (2021)

Microthermal-induced subcellular-targeted protein damage in cells on plasmonic nanosilver-modified surfaces evokes a two-phase HSP-p97/VCP response
por: Mistrik, Martin, et al.
Publicado: (2021)

Targeting the NPL4 Adaptor of p97/VCP Segregase by Disulfiram as an Emerging Cancer Vulnerability Evokes Replication Stress and DNA Damage while Silencing the ATR Pathway
por: Majera, Dusana, et al.
Publicado: (2020)

Common Chemical Inductors of Replication Stress: Focus on Cell-Based Studies
por: Vesela, Eva, et al.
Publicado: (2017)

Synergistic Interactions of Cannabidiol with Chemotherapeutic Drugs in MCF7 Cells: Mode of Interaction and Proteomics Analysis of Mechanisms
por: Alsherbiny, Muhammad A., et al.
Publicado: (2021)

Drug-Drug Interactions Between Cannabidiol and Lithium
por: Singh, Rani K., et al.
Publicado: (2020)

Potential Adverse Drug Events and Drug–Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use
por: Brown, Joshua D., et al.
Publicado: (2019)

Clinical implications of trials investigating drug‐drug interactions between cannabidiol and enzyme inducers or inhibitors or common antiseizure drugs
por: Patsalos, Philip N., et al.
Publicado: (2020)

Combination therapy with cannabidiol and chemotherapeutics in canine urothelial carcinoma cells
por: Inkol, Jordon M., et al.
Publicado: (2021)

Role of chemotherapeutic drugs in immunomodulation of cancer
por: Mukherjee, Oishi, et al.
Publicado: (2023)

Cannabidiol (CBD) as a Promising Anti-Cancer Drug
por: Seltzer, Emily S., et al.
Publicado: (2020)

Lipid-Drug Conjugates and Nanoparticles for the Cutaneous Delivery of Cannabidiol
por: Zielińska, Aleksandra, et al.
Publicado: (2022)

Interaction of standardized mistletoe (Viscum album) extracts with chemotherapeutic drugs regarding cytostatic and cytotoxic effects in vitro
por: Weissenstein, Ulrike, et al.
Publicado: (2014)

Chemotherapeutic Drugs: DNA Damage and Repair in Glioblastoma
por: Annovazzi, Laura, et al.
Publicado: (2017)

Research progress of anti-glioma chemotherapeutic drugs
por: Zhou, Yi-Shu, et al.
Publicado: (2022)

Actionable cancer vulnerability due to translational arrest, p53 aggregation and ribosome biogenesis stress evoked by the disulfiram metabolite CuET
por: Kanellis, Dimitris C., et al.
Publicado: (2023)

Is cannabidiol a drug acting on unconventional targets to control drug‐resistant epilepsy?
por: Rocha, Luisa, et al.
Publicado: (2020)

Ionic Interpretation of Drug Action in Chemotherapeutic Research
Publicado: (1956)

Tumour suppressor genes in chemotherapeutic drug response
por: Lai, Dulcie, et al.
Publicado: (2012)

13.2 CANNABIDIOL AS AN ANTIPSYCHOTIC DRUG
por: Guimaraes, Francisco, et al.
Publicado: (2018)

Alcohol-abuse drug disulfiram targets cancer via p97 segregase adapter NPL4
por: Skrott, Zdenek, et al.
Publicado: (2017)

Oncolytic herpes viruses, chemotherapeutics, and other cancer drugs
por: Braidwood, Lynne, et al.
Publicado: (2013)

Facilitating the Cellular Accumulation of Pt-Based Chemotherapeutic Drugs
por: Lambert, Ian Henry, et al.
Publicado: (2018)

Combinations of Cannabidiol and Δ(9)-Tetrahydrocannabinol in Reducing Chemotherapeutic Induced Neuropathic Pain
por: Sepulveda, Diana E., et al.
Publicado: (2022)

Antibody–drug conjugates as novel anti-cancer chemotherapeutics
por: Peters, Christina, et al.
Publicado: (2015)

Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19 †
por: Malinowska, Barbara, et al.
Publicado: (2021)

Repurposing Cannabidiol as a Potential Drug Candidate for Anti-Tumor Therapies
por: Wang, Fei, et al.
Publicado: (2021)

Improving the Brain Delivery of Chemotherapeutic Drugs in Childhood Brain Tumors
por: Triarico, Silvia, et al.
Publicado: (2019)

Flavonoids Synergistically Enhance the Anti-Glioblastoma Effects of Chemotherapeutic Drugs
por: Zhai, Kevin, et al.
Publicado: (2021)

Antibody-conjugated nanoparticles for target-specific drug delivery of chemotherapeutics
por: Kumari, Mamta, et al.
Publicado: (2023)

Herbal Interaction With Chemotherapeutic Drugs—A Focus on Clinically Significant Findings
por: Fasinu, Pius S., et al.
Publicado: (2019)

Multiphysics and Multiscale Analysis for Chemotherapeutic Drug
por: Zhang, Linan, et al.
Publicado: (2015)

Toxicological Properties of Δ(9)-tetrahydrocannabinol and Cannabidiol
por: Černe, Katarina
Publicado: (2020)

Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib
por: Gorini, Stefania, et al.
Publicado: (2018)

Anesthesia Medications and Interaction with Chemotherapeutic Agents
por: Watson, Jeremy, et al.
Publicado: (2021)

Does Cannabidiol Have a Benefit as a Supportive Care Drug in Cancer?
por: Lord, Sarah, et al.
Publicado: (2022)

Efficacy and Tolerance of Synthetic Cannabidiol for Treatment of Drug Resistant Epilepsy
por: Klotz, Kerstin A., et al.
Publicado: (2019)

Ultrasound-targeted microbubble destruction for chemotherapeutic drug delivery to solid tumors
por: Chen, Hong, et al.
Publicado: (2013)

Chemotherapeutic Drug-Regulated Cytokines Might Influence Therapeutic Efficacy in HCC
por: Wang, Chun-I, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2h8vhltmnadk1l4d3c6jrbr0qe